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Abstract
q  .  .We investigated the effect of ATP-sensitive K channel K openers pinacidil and cromakalim , and a K blockerATP ATP
 .glibenclamide on reperfusion-induced arrhythmias in pentobarbitone-anaesthetized rats. Arrhythmias were induced by reperfusion
 . following a 6 min ligation of the left main coronary artery. Rats were pretreated with pinacidil 0.1 or 0.3 mgrkg , or cromakalim 28 or
.  .56 mgrkg , or glibenclamide 5 mgrkg , or vehicle. Pinacidil and cromakalim produced dose-related reductions in blood pressure.
 .  .Pinacidil 0.1 mgrkg and cromakalim 56 mgrkg significantly decreased the incidence of reperfusion-induced ventricular fibrillation
and increased survival. Glibenclamide did not decrease ventricular fibrillation incidence, yet improved survival by increasing the
possibility of recovery from ventricular fibrillation. The present study suggests that both opening and blocking K channels mayATP
increase survival during coronary occlusion and reperfusion in anaesthetized rats. q 1997 Elsevier Science B.V. All rights reserved.
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1. Introduction
Since the identification of the ATP-dependent Kq chan-
 .  .nels K by Noma 1983 , their role in cardiac my-ATP
ocytes under physiologic and pathologic conditions has
been extensively investigated. Data on the effect on car-
diac arrhythmias of K modulators, however, have beenATP
inconsistent in the setting of myocardial ischaemia and
reperfusion.
In the normally oxygenated heart these channels are
found mainly in a closed state; however, during myocar-
dial ischaemia, as the intracellular ATP concentration falls
 q.and ischaemic metabolites ADP, lactate, H accumulate,
the open probability of K channels increases. TherebyATP
they enhance the repolarizing Kq current that, at least
partly, may be responsible for the shortening of the action
potential duration in ischaemic myocytes Gasser and
.Vaughan-Jones, 1990 . This effect could also result in a
decrease in voltage-dependent calcium current and in a
decrease in myocardial contractility. Such a mechanism
may have a natural protective role during myocardial
ischaemia that preserves the function of the myocardium
)  .  .Corresponding author. Tel.: 36-62 455-676; Fax: 36-62 321-107;
e-mail: lepran@phcol.szote.u-szeged.hu
 .for a longer time Escande and Cavero, 1992 . Non-uni-
form shortening of the action potential duration may result
in increased electrical inhomogeneity and may be responsi-
ble for development of arrhythmias during acute myocar-
dial ischaemia. Accordingly, K openers have beenATP
found by many authors to be arrhythmogenic during acute
ischaemia in vitro in isolated, perfused heart preparations
Wolleben et al., 1989; Di Diego and Antzelevitch, 1993;
.Fagbemi et al., 1993; Tosaki et al., 1993 . However, we
have demonstrated an antiarrhythmic effect of pinacidil
during the acute phase of myocardial infarction in con-
 .scious rats Lepran et al., 1996 , while Rees and Curtis
 .1995 found that the K opener RP 49356 did not haveATP
any action on the incidence of ischaemia-induced ventricu-
 .lar fibrillation in isolated rat heart. Smallwood et al. 1993
found that intra-coronarily administered pinacidil increased
the incidence of ventricular fibrillation in a 90 min occlu-
sionr5 h reperfusion in vivo canine model.
Inhibition of the opening of K channels duringATP
myocardial ischaemia could prevent the shortening of the
action potential duration and may offer an antiarrhythmic
effect. This has been demonstrated in in vitro experiments
using isolated perfused hearts Wolleben et al., 1989;
Kantor et al., 1990; Zhang et al., 1991; Tosaki et al., 1993;
.D’Alonzo et al., 1994 . Similar data have been published
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 .by Linz et al. 1994 who found glibenclamide and 5-hy-
droxydecanoate to be protective against reperfusion-in-
duced arrhythmias in isolated working rat hearts. More
 .recently, Rees and Curtis 1995 found glibenclamide not
to be antifibrillatory in acute myocardial ischaemia in
isolated rat hearts; however, the compound did reduce the
incidence of sustained ventricular fibrillation.
Both types of K modulatory agents are used inATP
 .therapy, K opening drugs e.g., pinacidil, nicorandilATP
for the treatment of hypertension and angina pectoris
Friedel and Brogden, 1990; Licata et al., 1995; Kaski,
.1995; Knight et al., 1995 , while K blocking sulphony-ATP
 .lureas e.g., glibenclamide have been administered for
many years to patients suffering from type II diabetes
 .mellitus Nattrass, 1986 . The reasons for the conflicting
results in the literature concerning their possible antiar-
rhythmicrantiischaemic effect may be due to differences
in the animal models and species used and other experi-
mental conditions. Therefore, the aim of the present exper-
iments was to compare the effects of representative KATP
 .openers cromakalim, pinacidil and a K blockerATP
 .glibenclamide on arrhythmias induced by reperfusion
following a brief period of myocardial ischaemia in anaes-
thetized rats.
2. Materials and methods
2.1. Animals
The experiments were performed on male Sprague-
Dawley rats, weighing 300–350 g. The animals were
housed six to a cage and allowed to have tap water and
 .laboratory rat chow Altromin, Godollo, Hungary ad libi-¨ ¨ ¨
tum until the experiment. The animals were handled ac-
cording to a protocol reviewed and approved by the Ethi-
cal Committee for the Protection of Animals in Research
of the Albert Szent-Gyorgyi Medical University, Szeged,¨
Hungary.
2.2. Coronary artery ligation and reperfusion
The animals were anaesthetized with pentobarbitone
 .sodium 60 mgrkg i.p. in a volume of 2 mlrkg . Acute
coronary ligation and reperfusion were achieved according
 .to Kane et al. 1984 . After tracheal canulation thoraco-
tomy was performed in the fourth intercostal space and the
heart was exposed. A loose loop of 5-0 atraumatic silk K
.890 H, Ethicon, Edinburgh, UK was placed around the
left main coronary artery approximately 2 mm from its
origin. Both ends of the ligature were led out of the
thoracic cavity through a flexible tube. The heart was set
back in its place and artificial respiration was started
immediately with 60 strokesrmin Harvard rodent ventila-
tor, model 683, Harvard Apparatus, South Natick, MA,
.USA .
Blood pressure was measured from the carotid artery
using a pressure transducer Gould-Statham, P23ID, Hugo
.Sachs Electronik, March-Hugstetten, Germany and was
recorded on an oscillographic recorder Watanabe, WTR
.331, Hugo Sachs Electronik . The catheter was filled with
 .isotonic saline that contained heparin 500 IUrml , but the
animals were not heparinized. The electrocardiogram lead
.II was recorded using subcutaneous needle electrodes.
After stabilization of the blood pressure and heart rate
 .approximately 5 min , the loose loop of the coronary
ligature was tightened and fixed by clamping on the silk
and thus regional myocardial ischaemia was produced.
After 6 min, the ligature was released to permit reperfusion
for 5 min.
Arrhythmias were detected during ischaemia and reper-
fusion and diagnosed in accordance with the Lambeth
conventions as ventricular tachycardia, ventricular fibrilla-
tion and other types of arrhythmias including single ex-
trasystoles, bigeminy, salvos and bradycardia Walker et
.al., 1988 . The onset and duration of arrhythmias were also
 .measured Lepran et al., 1983 . An arrhythmia score was
used to evaluate the incidence and duration of different
arrhythmias by giving a grade to each animal as follows:
0sno arrhythmias; 1s-10 s ventricular tachycardia or
other types of arrhythmias, no ventricular fibrillation; 2s
11–30 s ventricular tachycardia or other types of arrhyth-
mias, no ventricular fibrillation; 3s31–90 s ventricular
tachycardia or other types of arrhythmias, no ventricular
fibrillation; 4s91–180 s ventricular tachycardia or other
types of arrhythmias, andror -10 s reversible ventricular
fibrillation; 5s)180 s ventricular tachycardia or other
types of arrhythmias, andror )10 s reversible ventricular
fibrillation; 6s irreversible ventricular fibrillation.
No attempt was made to revert ventricular fibrillation to
sinus rhythm during ischaemia or reperfusion. At the end
of the experiments the hearts were excised and after
re-tightening the ligation they were perfused retrogradely
with 10 ml saline and 2 ml of 96% ethanol through the
aorta for determining the extent of the perfusable and
 .non-perfusable areas Lepran et al., 1983 . The bright
white area represented the perfusable area of the heart
while the colour of the non-perfusable myocardium did not
change. The hearts were cut along the epicardial border
line and the wet weight of the non-perfusable myocardium
was expressed as the percentage of the total weight of the
ventricles.
If the perfusion proved that the ligature was at an
 .inadequate place the whole heart could be perfused and
 .no change in the electrocardiogram QRS distorsion and
no decrease in blood pressure occurred after tightening of
the ligature, the given animal was excluded from the final
evaluation. On the basis of these criteria altogether five
animals were excluded.
2.3. Drug administration protocol
All drugs were dissolved in dimethyl sulfoxidersaline,
1:1 mixture and were applied in a volume of 100 mlrkg.
Each dose was prepared on the day of the experiment.
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 .Cromakalim Sigma, St. Louis, MO, USA was adminis-
tered at doses of 28 and 56 mgrkg i.v. 5 min prior to
coronary artery ligation. Pinacidil Research Biochemicals
.International, Natick, MA, USA was given 5 min before
coronary occlusion in 0.1 and 0.3 mgrkg doses i.v., and
 .glibenclamide Sigma was administered i.p. at 5 mgrkg
20 min before the occlusion.
2.4. Statistical e˝aluation
The percentage incidence of arrhythmias was calculated
and compared by using the x 2 method. All other variables
were expressed as mean"standard error of the mean
 .S.E.M. . For the comparison of the arrhythmia scores
Gehan’s generalized Wilcoxon test was applied. The other
parameters, after analysis of variance, were compared by
means of the modified ‘t’ statistic of Wallenstein et al.
 .1980 .
3. Results
3.1. Haemodynamic ˝ariables
No significant differences were detected in the heart
rate values measured before coronary artery ligation be-
tween the control animals and those given Kq channel
activators or blockers. The respective values 5 min after
pretreatment were: for control animals 412"7.4rmin n
.  .s17 , for cromakalim 413"8.9rmin ns15 and 402
 ."8.2rmin ns18 after doses of 28 and 56 mgrkg,
 .respectively, for pinacidil 404"9.6rmin ns22 and
 .397"11.3rmin ns18 after doses of 0.1 and 0.3
mgrkg, respectively, and for glibenclamide 20 min after
 .the administration 431"7.5rmin ns20 . The heart rate
 .during sinus rhythm did not change significantly in the
course of coronary artery occlusion or during reperfusion
between groups.
In the cromakalim- and pinacidil-pretreated groups the
mean arterial blood pressure was significantly decreased in
a dose-related manner immediately after drug administra-
 .tion Fig. 1 . This decrease was maintained for 5 min and
was present at the time of coronary occlusion with 56
mgrkg cromakalim and 0.3 mgrkg pinacidil. However,
blood pressure with 28 mgrkg cromakalim or 0.1 mgrkg
pinacidil had recovered by the time of tightening the
coronary ligation. After coronary artery ligation blood
pressure fell in all groups. This fall was significantly
attenuated by 28 mgrkg cromakalim, with all other groups
exhibiting similar falls in pressure. In surviving animals,
blood pressure recovered to levels approaching baseline in
 .all groups Fig. 1 . The mean blood pressure of the
glibenclamide-treated group showed no significant differ-
ence compared to the control throughout the experiment
104"5.5 vs. 102"4.6 mmHg 1 min before and 58"7.4
.vs. 56"6.5 mmHg 1 min after occlusion .
Fig. 1. Effect of pinacidil and cromakalim on mean blood pressure during
coronary artery occlusion and reperfusion in anaesthetized rats. The
broken line with open circles represents the control group. Open triangles,
0.1 mgrkg pinacidil; open squares, 0.3 mgrkg pinacidil; filled triangles,
28 mgrkg cromakalim; filled squares, 56 mgrkg cromakalim. Pinacidil
 .and cromakalim were given during a 1 min infusion Inf. 5 min before
the start of coronary artery ligation. Asterisks denote statistically signifi-
 .cant difference from the control group P -0.05 .
The underperfused region of the heart, measured at the
termination of the experiment by the in vitro perfusion
method, was well demarcated and extended to the proxi-
mal and lateral free wall of the left ventricle. The values in
the control, 0.1 and 0.3 mgrkg pinacidil, 28 and 56
mgrkg cromakalim and glibenclamide groups amounted to
 .  .37.7"2.0% ns10 , 38.1"0.9% ns18 , 39.0"1.1%
 .  .  .ns15 , 38.5"1.5% ns12 , 38.8"1.2% ns16 and
 .38.6"1.5% ns20 of the wet weight of the ventricles,
respectively.
3.2. Arrhythmias during ischaemia
The main focus of this study was to investigate reperfu-
sion-induced arrhythmias, therefore we applied 6 min of
ischaemia which is not enough for the development of
severe ischaemia-induced arrhythmias. In all groups is-
chaemia-induced arrhythmias started at 5 min of the occlu-
sion period. In case of ventricular fibrillation at the time of
the onset of reperfusion the experiment was terminated and
the animal was considered dead during ischaemia.
Significantly more animals survived this period in the
high-dose cromakalim-treated group compared to the con-
 .trol animals 94% vs. 65%, P-0.05 .
During ischaemia the number of animals without any
arrhythmia was significantly higher in the 56 mgrkg
cromakalim group and the 0.1 mgrkg pinacidil group
 .50% and 64% vs. 12%, P-0.05 , and the incidence of
 .ventricular tachycardia 6% and 18% vs. 47%, P-0.05
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Table 1
Effect of pinacidil, cromakalim and glibenclamide on the incidence of arrhythmias during reperfusion following 6 min of coronary occlusion in
anaesthetized rats
 .Group Dose n Died Incidence of arrhythmias No.r% Arrhythmia score
 .  .mgrkg No.r% None VF VT Other
Control 11 10r91 0r0 11r100 7r64 6r55 5.91"0.09
a a aPinacidil 0.10 19 6r32 4r21 7r37 14r74 13r68 3.42"0.54
a0.30 15 9r60 1r7 12r80 14r93 12r80 5.13"0.41
Cromakalim 0.028 12 11r92 0r0 11r92 10r83 9r75 5.75"0.25
a a a0.056 17 5r29 0r0 6r35 15r88 13r77 4.47"0.30
a a a aGlibenclamide 5.00 16 3r19 0r0 13r81 16r100 15r94 4.69"0.24
ns total number of animals; No.snumber of animals exhibiting the given response; %spercentage of the animals exhibiting the given response.
VFsventricular fibrillation; VTsventricular tachycardia; Othersextrasystoles, salvos, andror bigeminy. a P-0.05 compared with the control group.
and ventricular fibrillation 6% and 14% vs. 41%, P-
.0.05 was significantly lower than in the control group.
3.3. Reperfusion arrhythmias
Arrhythmias induced by reperfusion started within 10–
30 s following the release of the coronary artery ligature.
Significantly more animals survived the reperfusion period
in the high-dose cromakalim, 0.1 mgrkg pinacidil and in
the glibenclamide groups, compared to the control group
 .Table 1 . The incidence of ventricular fibrillation was
significantly decreased by 56 mgrkg cromakalim and 0.1
mgrkg pinacidil. In spite of the significant protective
effect of glibenclamide on the survival rate, the incidence
 .of ventricular fibrillation did not change Table 1 . How-
ever, the possibility to revert fibrillation spontaneously was
significantly improved 10r13 vs. 1r11 in controls, P-
.0.01 .
The arrhythmia scores, representing the incidence and
duration of arrhythmias and the survival rate as a single
number, were significantly reduced by 0.1 mgrkg
pinacidil, 56 mgrkg cromakalim and 5 mgrkg gliben-
 .clamide Table 1 .
The appearance of arrhythmias in animals having no
dysrhythmias was defined at 5 min of reperfusion. No
significant differences were noted concerning the appear-
ance of the first arrhythmia and the duration of the period
that was characterized by arrhythmias time between first
.and the end of the last arrhythmic attack during reperfu-
sion, except in the animals pretreated by 0.1 mgrkg
pinacidil, where – due to many animals showing no dys-
rhythmias at all – the calculated appearance of arrhythmias
occurred significantly later than in the control group 1.2
."0.46 vs. 0.1"0.04 min, P-0.05 . The lengths of
arrhythmic attacks were calculated taking only the surviv-
ing animals into consideration. As only one animal sur-
vived the reperfusion period in the control group, statistical
comparison concerning the duration of different arrhyth-
mic attacks was not possible i.e., ventricular fibrillation
.and tachycardia, other arrhythmias .
4. Discussion
Inducing reperfusion arrhythmias, appearing after the
restoration of blood flow following a brief myocardial
ischaemia, is a widely used method for the investigation of
potentially antiarrhythmic drugs. These arrhythmias are
easily reproducible under precise conditions both in vitro
and in vivo. The duration of preceding ischaemia is one
determinant of the severity of reperfusion arrhythmias
 .Manning and Hearse, 1984 . In the present experiments
we intended to produce severe and reproducible arrhyth-
mias during reperfusion. To avoid sustained ischaemia-in-
duced arrhythmias that would confound the analysis of
reperfusion arrhythmias we applied 6 min of coronary
artery ligation. This duration of coronary occlusion is
sufficient to prime the heart to develop severe arrhythmias
consistently 10–30 s following the onset of reperfusion
 .Lepran and Szekeres, 1992 . The model may relate to
reperfusion following cardiac surgery, thrombolysis or
spontaneous release of a coronary artery vasospasm in
variant angina in clinical settings Manning and Hearse,
.1984 .
The present results demonstrate that pretreatments ei-
ther with K channel opener drugs pinacidil or cro-ATP
.  .makalim or a K blocker glibenclamide may offerATP
significant beneficial effects against reperfusion-induced
arrhythmias in anaesthetized rats albeit by different mecha-
nisms. Both types of pretreatments significantly decreased
the incidence of sustained ventricular fibrillation and
markedly increased the number of the surviving animals
during reperfusion following a brief period of ischaemia.
It has been shown in a number of studies that drugs
opening K channels offer protection against ischaemiaATP
and reperfusion-induced myocardial injury and arrhyth-
mias Yao and Gross, 1994; Grover, 1994; Yao et al.,
.1993; Cole et al., 1991 . Others have found that these
agents may aggravate reperfusion injury and result in
proarrhythmic activity Kaiser et al., 1994; Black and
Lucchesi, 1994; Delacoussaye et al., 1993; Chi et al.,
.1990; Tosaki and Hellegourach, 1994 . The action poten-
tial duration shortening effect of K channel openers canATP
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 .indeed be proarrhythmic Haverkamp et al., 1995 , yet it
may result in inhibition of arrhythmias caused by non-re-
entrant mechanisms, especially spontaneous and triggered
 .arrhythmias Wilde and Janse, 1994 .
The sensitivity of myocytes to K openers duringATP
ischaemic conditions may increase, whereby the hitherto
subthreshold doses can produce a pharmacologic effect.
For this reason the action potential duration shortening
 .effect i.e., the arrhythmogenic potential of K channelATP
openers in the normally oxygenated myocardium may have
 .been overemphasized Wilde, 1994 . According to Fish et
 .al. 1990 , K channel openers can diminish triggeredATP
arrhythmias at concentrations that do not affect the action
potential duration in non-ischaemic tissue. Grover et al.
 .1995 have also concluded that the action potential dura-
tion shortening effect of cromakalim does not correlate
with its cardioprotective effect in anaesthetized dogs.
The present in vivo experiments confirm that KATP
channel openers indeed protect against reperfusion-induced
arrhythmias in anaesthetized rats. The ‘antiarrhythmic’
action offered by these agents, however, did not correlate
with their blood pressure lowering effect. In higher doses,
when both pinacidil and cromakalim significantly de-
creased the mean arterial blood pressure of the animals,
only cromakalim was effective against ventricular fibrilla-
tion, the antiarrhythmic effect of pinacidil diminished at
high dosage. Furthermore, the changes in blood pressure as
a response to the lower doses of K channel openersATP
were transient and returned to the baseline values by the
time of occlusion. This return was not due to increased
heart rate at the time of the coronary ligation. Therefore, a
peripheral vasodilating effect and a decrease in afterload
may not be a contributing factor in the protective effect;
moreover, the sustained fall in blood pressure may aggra-
vate the effect of ischaemiarreperfusion because of the
decrease in coronary perfusion pressure. The question,
whether the loss of protection by pinacidil in a higher dose
was due to direct cardiac or to some vascular effects, may
be resolved by consideration of the actions of cardioselec-
 .tive K channel openers. Indeed, Grover et al. 1995ATP
found that a cardioselective K channel opener, BMS-ATP
180448, possessed a cardioprotective effect similar to that
of pinacidil and cromakalim, while having virtually no
vasodilating effect in peripheral arterial smooth muscle.
The possible mechanisms of the observed beneficial
effects of K channel opener drugs against ischaemiaATP
and reperfusion injury and arrhythmias are still the subject
of speculation. An increase in coronary collateral blood
flow may limit the extent of developing ischaemia
 .Nienaber et al., 1983 and thereby reperfusion-induced
myocardial damage. However, although pinacidil and cro-
makalim could improve the collateral flow due to their
vasodilatory effect, this mechanism is unlikely to play a
key role in the prevention of arrhythmias in the rat because
of the very limited collateral flow present in this species
 .Maxwell et al., 1987 .
The decrease in calcium influx caused by the shortening
of the action potential duration selectively in ischaemic
myocardial fibres may be an important factor in the pre-
 .vention of reperfusion arrhythmias Brooks et al., 1995 .
Since the voltage-dependent calcium influx decreases fol-
lowing the activation of K channels, K openerATP ATP
drugs may exert their beneficial effects against ventricular
fibrillation through the inhibition of calcium accumulation
in myocytes both during myocardial ischaemia and reper-
fusion. Such an effect may inhibit the development of
re-entry arrhythmias and also results in decreased contrac-
tility and energy sparing, thereby slowing the development
of ischaemic changes.
One of the electrophysiological consequences of re-
gional myocardial ischaemia is the shortening of the action
potential duration in hypoxic myocytes that leads to a
marked electrical inhomogeneity between normoxic and
ischaemic tissues, increasing the possibility of the develop-
 .ment of severe arrhythmias Janse and Wit, 1989 . This
inhomogeneity exists also within different areas of the
hypoxic tissues, between severely and less seriously in-
jured myocardial fibres. K opener compounds couldATP
further shorten the action potential duration of the slightly
injured fibres in the heart during ischaemia and reperfu-
sion, making the injured myocardium more homogenous
and diminishing the development of life threatening ven-
tricular arrhythmias.
It was shown that among diabetic patients, receiving
first-generation oral antidiabetic drug treatment tolbuta-
.mide, phenformin , the mortality from cardiovascular
causes was significantly higher than in patients treated
with insulin or placebo Meinert et al., 1970; Gilbert et al.,
.1975 . Oral sulphonylurea antidiabetics, by blocking KATP
channels also in the myocardium, seem to impair the
natural metabolic protection offered by the opening of
these channels during myocardial ischaemia. In a more
recent study, however, investigating 232 patients with
non-insulin-dependent diabetes mellitus, the second-gener-
ation antidiabetic agent glibenclamide protected against
arrhythmias in the acutely ischaemic myocardium Cac-
.ciapuoti et al., 1991 . Similar results were published by
 .Lomuscio et al. 1994 . Thus it seems reasonable to distin-
guish between first- and second-generation sulphonylurea
compounds concerning their cardiac effects. Ballagi-
 .Pordany et al. 1990 demonstrated an antiarrhythmic ef-
fect after using second-generation sulphonylurea antidia-
betic drugs, and a proarrhythmic effect by using first-gen-
eration compounds in the ischaemic rat heart in vivo.
 .Pogatsa et al. 1988 found that in digitalized, non-
insulin-dependent diabetic patients glibenclamide pro-
tected, while tolbutamide offered no protection against
multifocal ectopic beats. In our in vivo experiments,
glibenclamide also protected against the development of
reperfusion-induced irreversible ventricular fibrillation in
anaesthetized rats. This significant protection occurred in
spite of the well known hypoglycaemic effect of the drug
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that can be harmful during myocardial infarction. We
assume that the blockade of K channels by gliben-ATP
clamide was beneficial because it probably prevented the
shortening of action potential duration and that of the
refractory period of ischaemic myocardial fibres Tweedie
.et al., 1993 . Thus it seems conceivable that the decrease
in electrical inhomogeneity of the heart may play a role in
the prevention of fatal ventricular arrhythmias during the
early phase of reperfusion.
In conclusion, both the opening and inhibition of ATP-
sensitive Kq channels may result in protection against
reperfusion-induced arrhythmias in anaesthetized rats. This
acute effect against lethal ventricular arrhythmias is proba-
bly due to the decreased electrical inhomogeneity between
the ischaemic and non-ischaemic myocardium or within
the ischaemic zone between more and less severely injured
tissue islets during ischaemia and reperfusion. Such an
effect could be achieved differently by the two types of the
studied compounds, i.e., openers and blockers of the KATP
channels. The K channel openers probably shorten theATP
action potential duration of less severely damaged myofila-
ments, thereby making them similar to the more seriously
injured tissues. K channel blockers, on the other hand,ATP
possibly inhibit the shortening of the action potential dura-
tion in less severely ischaemic tissues, making their action
potential duration similar to that in normoxic myocytes.
Both mechanisms may tend to decrease the electrical
inhomogeneity among islets of myocytes that were created
by the developing ischaemia and were further intensified
by rapid reperfusion.
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